Milind Deshpande
2016
In 2016, Milind Deshpande earned a total compensation of $3M as Director, President and Chief Executive Officer at Achillion Pharmaceuticals, a 213% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $218,144 |
|---|---|
| Option Awards | $2,153,727 |
| Salary | $590,000 |
| Other | $8,310 |
| Total | $2,970,181 |
Deshpande received $2.2M in option awards, accounting for 73% of the total pay in 2016.
Deshpande also received $218.1K in non-equity incentive plan, $590K in salary and $8.3K in other compensation.
Rankings
In 2016, Milind Deshpande's compensation ranked 3,231st out of 14,075 executives tracked by ExecPay. In other words, Deshpande earned more than 77.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,231 out of 14,075 | 77th |
Division Manufacturing | 1,118 out of 5,489 | 80th |
Major group Chemicals And Allied Products | 329 out of 1,895 | 83rd |
Industry group Drugs | 238 out of 1,538 | 85th |
Industry Pharmaceutical Preparations | 185 out of 1,176 | 84th |
Source: SEC filing on April 17, 2017.
Deshpande's colleagues
We found four more compensation records of executives who worked with Milind Deshpande at Achillion Pharmaceuticals in 2016.
2016
Joel Barrish
Achillion Pharmaceuticals
Chief Scientific Officer
2016
David Apelian
Achillion Pharmaceuticals
Chief Medical Officer
2016
Joseph Truitt
Achillion Pharmaceuticals
Executive Vice President and Chief Commercial Officer
2016
Mary Fenton
Achillion Pharmaceuticals